Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.010
+0.010 (1.00%)
Apr 1, 2025, 10:32 AM EDT - Market open
Cytosorbents Employees
Cytosorbents had 186 employees as of December 31, 2023. The number of employees decreased by 12 or -6.06% compared to the previous year.
Employees
186
Change (1Y)
-12
Growth (1Y)
-6.06%
Revenue / Employee
$191,368
Profits / Employee
-$111,392
Market Cap
55.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTSO News
- 14 hours ago - Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 hours ago - CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 11 days ago - CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - PRNewsWire
- 4 weeks ago - CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller - GlobeNewsWire
- 3 months ago - CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - GlobeNewsWire
- 3 months ago - CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 5 months ago - CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India - GlobeNewsWire
- 5 months ago - Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript - Seeking Alpha